Herbal medicine market seen hitting $540.9B by 2035

Market Research Future projects the global herbal medicine market will more than double from $226.3 billion in 2025 to $540.9 billion by 2035, driven by rising demand for natural wellness products, faster regulatory pathways and new supply-chain technology. The report points to especially strong growth in Asia-Pacific, e-commerce and herbal supplements.

Why it matters: - The herbal medicine market is moving from niche wellness category to a mainstream global health segment. - Faster consumer adoption, regulatory updates and digital supply-chain tools are shortening product development cycles and expanding access. - The market’s growth also reflects a broader shift toward preventive care and plant-based chronic-disease management.

What happened: - Market Research Future projects the global herbal medicine market will reach $540.90 billion by 2035. - The market is forecast to rise from $246.90 billion in 2026. - The report pegs the compound annual growth rate at 9.1% for 2026-2035. - The market base was estimated at $226.30 billion in 2025. - The report links the growth outlook to consumer behavior, regulatory modernization and technology-led supply-chain change.

The details: - The World Health Organization estimates 80% of the world’s population has used some form of herbal cure. - Out-of-pocket spending on plant-based health products has surpassed $95 billion a year across emerging economies. - Euromonitor research shows Millennials and Gen-Z in North America and Europe are buying natural products 38% more than the previous generation. - The European Medicines Agency added 24 botanicals to its Community Herbal Monograph registry between 2023 and 2025. - The FDA updated its Botanical Drug Development guidance in 2024. - China’s National Medical Products Administration introduced a fast-track classification for classical formulas. - Governments across Asia have committed more than $4.8 billion in cumulative public funding to traditional medicine infrastructure since 2021. - India’s Ministry of AYUSH allocated $620 million for its 2024-2026 cycle to digitize quality-testing labs and build a centralized botanical fingerprint database. - Online retail now accounts for 19% of herbal medicine market income, up from 11% in 2020. - Subscription-based supplement services grew 27% year over year in North America in 2024. - E-commerce is advancing at a 10.8% CAGR, the fastest among distribution channels. - Herbal pharmaceuticals held a 28.3% revenue share in 2025. - Herbal dietary supplements are the fastest-expanding product line, at a 10.2% CAGR through 2035. - Herbal beauty and personal care reached $41.80 billion in 2025. - Tablets and capsules held a 42.5% revenue share in 2025. - Teas and infusions are the fastest-growing dosage form, at an 11.9% CAGR. - Hospital and retail pharmacies remained the largest distribution channel with a 35.9% revenue share in 2025. - Turmeric held a 21.1% revenue share in 2025. - Ginseng is the fastest-growing medicinal plant, at an 11.1% CAGR. - Asia-Pacific held about 48.2% of the market in 2025 and remains the dominant region. - China accounted for 41.3% of the regional share. - India is growing at a 10.4% CAGR and has more than 800,000 practitioners registered on its digital platform. - North America held a 22.5% share in 2025. - Europe is the fastest-growing region, with an 11.5% CAGR through 2035. - Germany leads Europe with a 12.6% CAGR and generates more than $4.1 billion in annual pharmacy sales from its phytopharmaceutical sector. - The market remains fragmented, with the top five companies holding an estimated 18% to 24% of global revenue.

Between the lines: - The report suggests the next phase of growth will depend less on traditional herbal branding and more on proof, traceability and regulated product standards. - AI screening, precision fermentation and blockchain-backed traceability are becoming competitive advantages rather than experimental add-ons. - Fragmentation leaves room for both multinational drugmakers and digitally native direct-to-consumer brands to keep gaining share. - Insurance coverage and clinical integration could be the biggest unlock if more markets follow Germany and Japan.

What's next: - AI-driven formulation, personalization and nutrigenomics are expected to support premium subscription products over the next decade. - Sustainability pressure is likely to push more companies toward controlled-environment agriculture and certified sourcing. - Precision fermentation could reduce reliance on seasonal crops for high-value compounds such as ginsenosides and artemisinin. - The report expects broader clinical evidence generation to support further insurance integration and market expansion.

The bottom line: - Herbal medicine is evolving into a larger, more regulated and more technology-driven global market, with Asia-Pacific leading growth and e-commerce accelerating access.